BIOND BIOLOGICS
Biond Biologics is a discovery and development company in the prosperous and evolving field of cancer immunotherapy and autoimmune disorders. Biond aims to translate high quality science into breakthrough therapies that will address unmet medical needs while focusing on innovative drugs. Biond is an Israeli company located at Galilee region, combining excellent science and out of the box innovation.
BIOND BIOLOGICS
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2016-04-21
Address:
Misgav, HaZafon, Israel
Country:
Israel
Website Url:
http://www.biondbio.com
Total Employee:
11+
Status:
Active
Contact:
+972-4-8844337
Email Addresses:
[email protected]
Total Funding:
32 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager WordPress Wordpress Plugins Global Site Tag
Similar Organizations
Exo Therapeutics
Exo Therapeutics is a small molecule drug discovery and development company.
Frontier Biotechnologies
Frontier Biotechnologies is a commercial-stage bio-pharmaceutical company.
MigVax
MigVax is an Israeli medical technology startup.
NaturNorth Technologies
NaturNorth Technologies is a pioneering biotech discovery and development company.
Sciwind Biosciences
Sciwind Biosciences is a drug research and development company for metabolic diseases.
Silicon Therapeutics
Silicon Therapeutics is a fully integrated drug design, research, and development company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Deep Insight
Deep Insight investment in Series C - Biond Biologics
Heritage Group
Heritage Group investment in Series C - Biond Biologics
Harel Insurance Investments and Financial Services
Harel Insurance Investments and Financial Services investment in Series C - Biond Biologics
Harel Insurance Investments and Financial Services
Harel Insurance Investments and Financial Services investment in Series B - Biond Biologics
Celgene
Celgene investment in Series B - Biond Biologics
Israel Biotech Fund
Israel Biotech Fund investment in Series B - Biond Biologics
SBI Japan-Israel Innovation Fund
SBI Japan-Israel Innovation Fund investment in Series B - Biond Biologics
Official Site Inspections
http://www.biondbio.com Semrush global rank: 3.68 M Semrush visits lastest month: 3.81 K
- Host name: israel15.jetserver.net
- IP address: 81.218.83.71
- Location: Jerusalem Israel
- Latitude: 31.7808
- Longitude: 35.2287
- Timezone: Asia/Jerusalem
More informations about "Biond Biologics"
Biond Biologics - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +972-4-8844337 Biond Biologics is a discovery and development company in the prosperous and evolving field of cancer immunotherapy and …See details»
About Biond Biologics – Biond Biologics
Biond is an innovative clinical stage biotech company developing breakthrough immunotherapies and a pioneering intracellular drug delivery platform for the treatment of cancer patients.See details»
Biond Biologics Company Profile | Management and Employees …
Www.biondbio.com Biond Biologics Profile and History Biond Biologics is a drug discovery and development company focused on developing innovative therapies for novel oncology targets …See details»
Biond Biologics Ltd - LinkedIn
Biond Biologics is an Israeli clinical-stage biopharmaceutical company Biond is an innovative biotech company developing breakthrough immunotherapies and a pioneering intracellular …See details»
Biond Biologics Ltd: Contact Details and Business Profile
Biond Biologics is an Israeli clinical-stage biopharmaceutical company Biond is an innovative biotech company developing breakthrough immunotherapies and a pioneering intracellular …See details»
Biond Biologics and Sanofi Enter into Global Licensing Agreement …
“We are thrilled to partner with Sanofi, an organization with a global footprint and exceptional drug development and commercialization capabilities,” said Ori Shilo, Co-Founder and Chief ...See details»
Biond Biologics - Company Profile - Tracxn
Oct 22, 2024 Biond Biologics - Developer of immunotherapies for oncology and autoimmune diseases. Raised a total funding of $32M over 2 rounds from 7 investors. Founded by Tehila …See details»
Biond Biologics - Craft
Biond Biologics has 5 employees at their 1 location and $17 m in total funding,. See insights on Biond Biologics including office locations, competitors, revenue, financials, executives, …See details»
Biond Biologics - Overview, News & Similar companies - ZoomInfo
May 31, 2022 www.biondbio.com. Revenue <$5 Million. Industry Business Services General Business Services . Recent News & Media. Biond Biologics Announces Presentation of BND …See details»
Biond Biologics Ltd - edgein.io
Biond Biologics is an Israeli clinical-stage biopharmaceutical company Biond is an innovative biotech company developing breakthrough immunotherapies and a pioneering intracellular …See details»
Biond Biologics Ltd. (Biond Biologics Ltd.) - 药物管线_专利_临床试 …
Using INspire, Biond targets, for example, the RAS-RAF signaling pathway, which is a driver in many cancers. Company contact: Tal Sines VP of Business Development Biond Biologics Ltd. …See details»
Biond Biologics CEO and Key Executive Team | Craft.co
Biond Biologics's Co-Founder, Chairperson & Chief Executive Officer is Tehila Ben Moshe. Other executives include Ori Shilo, Co-Founder & Chief Financial Officer; Yair Sapir, Chief Operation …See details»
Collaborations – Biond Biologics
Our vision is to deliver innovative medicines to patients while fostering synergistic long-term collaborations with leading biopharmaceutical companies and by partnering with leading …See details»
Biond Biologics and Sanofi Enter into Global Licensing ... - Nasdaq
Jan 12, 2021 For more information, visit www.biondbio.com. Company contact: Itay Friedman , M.D.VP Clinical Development Biond Biologics Ltd. +972-4 884 4337 [email protected]See details»
Biond Biologics and Sanofi Enter into Global Licensing ... - BioSpace
Jan 12, 2021 Biond Biologics Ltd. ("Biond" or the "Company"), a privately-held biopharmaceutical company, developing novel immunotherapies for cancer and a platform …See details»
Corporate Presentation - Biond Bio
Pipeline of first-in-class drug candidates 6 Program Discovery Pre-Clinical Development IND enabling Studies Phase 1 Immuno-Oncology BND-22: ILT2 (LILRB1)See details»
BND-35 - Drug Targets, Indications, Patents - Synapse
BND-35 is a Novel and Unique Anti-ILT3/LILRB4 Antibody for Remodeling the Tumor Microenvironment BND-35-001 trial includes unique combination arms with anti-EGFR …See details»
Biond Biologics and Sanofi Enter into Global Licensing Agreement …
Jan 12, 2021 Biond Biologics and Sanofi Enter into Global Licensing Agreement for BND-22, a Novel Immune Checkpoint Inhibitor Targeting the ILT2 Receptor Biond to receive $125 million …See details»
Scientific Advisory Board – Biond Biologics
Giovanni Abbadessa is an MD, PhD, who specialized in Oncology in Italy, and in Genetical Oncology between the US and Italy. He is Vice President, Head of Oncology Early …See details»